HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Francesco Bertoni Selected Research

Proteasome Inhibitors

10/2019IDH2 inhibition enhances proteasome inhibitor responsiveness in hematological malignancies.
6/2012An open-label phase 2 study of twice-weekly bortezomib and intermittent pegylated liposomal doxorubicin in patients with ovarian cancer failing platinum-containing regimens.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Francesco Bertoni Research Topics

Disease

81Neoplasms (Cancer)
05/2024 - 02/2005
64Lymphoma (Lymphomas)
05/2024 - 04/2002
18Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
11/2023 - 07/2005
13B-Cell Lymphoma (Lymphoma, B Cell)
05/2024 - 01/2007
12Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
10/2020 - 11/2004
8B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
11/2023 - 01/2007
7Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
01/2018 - 08/2011
6Non-Hodgkin Lymphoma (Lymphosarcoma)
06/2023 - 03/2005
6Prostatic Neoplasms (Prostate Cancer)
01/2021 - 12/2016
6Leukemia
10/2020 - 10/2011
5Marginal Zone B-Cell Lymphoma (MALT Lymphoma)
02/2024 - 04/2002
5Multiple Myeloma
10/2019 - 01/2007
4Hematologic Neoplasms (Hematological Malignancy)
02/2024 - 10/2019
4Ovarian Neoplasms (Ovarian Cancer)
01/2022 - 10/2006
4Genetic Translocation (Chromosomal Translocation)
11/2015 - 01/2006
3Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
11/2023 - 01/2019
3T-Cell Lymphoma (Lymphoma, T Cell)
11/2023 - 03/2015
3Trisomy (Trisomies)
06/2023 - 01/2018
3Neoplasm Metastasis (Metastasis)
12/2022 - 10/2008
3Chromosome Aberrations (Chromosome Abnormalities)
01/2012 - 01/2009
2Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
02/2024 - 01/2019
2Melanoma (Melanoma, Malignant)
12/2022 - 01/2021
2Thrombocytopenia (Thrombopenia)
12/2022 - 01/2022
2Carcinogenesis
01/2018 - 04/2015
2Breast Neoplasms (Breast Cancer)
01/2017 - 04/2015
2Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
11/2016 - 08/2012
2Infections
02/2012 - 03/2005
2Lymphoproliferative Disorders (Lymphoproliferative Disorder)
05/2010 - 07/2006
2Uniparental Disomy
05/2008 - 07/2006
1Ataxia Telangiectasia (Louis Bar Syndrome)
11/2023

Drug/Important Bio-Agent (IBA)

15Proteins (Proteins, Gene)FDA Link
08/2022 - 10/2008
13DNA (Deoxyribonucleic Acid)IBA
02/2024 - 01/2006
8Immunoconjugates (Immunoconjugate)IBA
05/2024 - 01/2019
8RNA (Ribonucleic Acid)IBA
01/2023 - 05/2011
7Rituximab (Mabthera)FDA Link
02/2024 - 02/2005
7Phosphotransferases (Kinase)IBA
11/2023 - 04/2015
7OTX015IBA
12/2019 - 04/2015
6NF-kappa B (NF-kB)IBA
06/2023 - 11/2004
6Transcription Factors (Transcription Factor)IBA
01/2023 - 01/2006
6AntigensIBA
01/2022 - 07/2005
6MicroRNAs (MicroRNA)IBA
11/2021 - 02/2007
6Biomarkers (Surrogate Marker)IBA
11/2021 - 01/2011
5venetoclaxIBA
02/2023 - 06/2019
5Anaplastic Lymphoma KinaseIBA
01/2018 - 08/2011
5Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA
01/2012 - 05/2007
4Agammaglobulinaemia Tyrosine KinaseIBA
01/2023 - 09/2016
4ChromatinIBA
04/2022 - 03/2015
4Histone Deacetylase InhibitorsIBA
01/2021 - 03/2015
4Anti-Bacterial Agents (Antibiotics)IBA
01/2016 - 03/2005
3LigandsIBA
12/2023 - 10/2006
3Monoclonal AntibodiesIBA
11/2023 - 09/2016
3Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
01/2023 - 06/2019
3ParaffinIBA
01/2023 - 10/2008
3UbiquitinIBA
01/2021 - 12/2007
3Antineoplastic Agents (Antineoplastics)IBA
01/2021 - 09/2016
3Ligases (Synthetase)IBA
01/2021 - 12/2007
3ibrutinibIBA
01/2018 - 01/2016
3EverolimusFDA Link
01/2017 - 07/2012
3Doxycycline (Periostat)FDA LinkGeneric
01/2016 - 11/2011
3Cyclin D1IBA
11/2015 - 01/2007
2Chlorambucil (Leukeran)FDA Link
02/2024 - 04/2002
2Lapatinib (GW572016)FDA Link
12/2023 - 01/2023
2idelalisibIBA
12/2023 - 01/2023
2copanlisibIBA
11/2023 - 10/2020
2OxazolesIBA
06/2023 - 10/2020
2Sirolimus (Rapamycin)FDA Link
02/2023 - 06/2019
2ProdrugsIBA
01/2023 - 12/2020
2Therapeutic UsesIBA
12/2022 - 01/2018
2TubulinIBA
12/2022 - 01/2020
2Bendamustine HydrochlorideFDA Link
10/2022 - 07/2007
2polatuzumab vedotinIBA
10/2022 - 12/2020
2MethyltransferasesIBA
01/2022 - 01/2017
2Protein Isoforms (Isoforms)IBA
11/2021 - 12/2007
2Cytarabine (Cytosar-U)FDA LinkGeneric
12/2020 - 01/2020
2TrabectedinIBA
12/2020 - 01/2019
2Kruppel-Like Transcription Factors (Kruppel-Like Factors)IBA
07/2020 - 01/2018
2Class 2 Receptor-Like Protein Tyrosine PhosphatasesIBA
07/2020 - 01/2018
2Proteasome InhibitorsIBA
10/2019 - 06/2012
2Small Interfering RNA (siRNA)IBA
10/2019 - 12/2007
2TOR Serine-Threonine KinasesIBA
06/2019 - 07/2012
2pixantrone (BBR 2778)IBA
01/2019 - 01/2018
2Pyruvate Dehydrogenase Complex (Dehydrogenase Complex, Pyruvate)IBA
01/2018 - 01/2018
2Circulating Tumor DNAIBA
01/2018 - 01/2018
2Messenger RNA (mRNA)IBA
01/2017 - 10/2008
2EnzymesIBA
01/2017 - 01/2017
2Formaldehyde (Formol)FDA Link
08/2012 - 10/2008
2fludarabineIBA
03/2012 - 12/2011
1loncastuximab tesirineIBA
05/2024
1Cytotoxins (Cytolysins)IBA
02/2024
1N- (2- amino- 5- fluorobenzyl)- 4- (N- (pyridine- 3- acrylyl)aminomethyl)benzamideIBA
02/2024
1BAY 1895344IBA
11/2023
1naratuximab emtansineIBA
11/2023
1Interleukin-6 (Interleukin 6)IBA
11/2023
1Chimeric Antigen ReceptorsIBA
11/2023

Therapy/Procedure

29Therapeutics
05/2024 - 04/2002
5Drug Therapy (Chemotherapy)
01/2022 - 11/2011
4Immunotherapy
11/2023 - 11/2020
2Radiotherapy
03/2014 - 11/2011
2Time-to-Treatment
01/2012 - 01/2010
2Organ Transplantation
05/2010 - 07/2006